Literature DB >> 11791684

The Sophia Anatomical Infant Nose-Throat (Saint) model: a valuable tool to study aerosol deposition in infants.

H M Janssens1, J C de Jongste, W J Fokkens, S G Robben, K Wouters, H A Tiddens.   

Abstract

Relatively little is known about the variables that influence lung deposition of inhaled aerosols in children. A model of the upper airways of an infant could be a useful tool to study these variables in vitro. The objective of this study was to construct an anatomically correct model of the upper airways of a young child. A routine three-dimensional (3D) CT scan of the skull and neck of a child was selected that included the airway from the nasal cavity down to the subglottic region. The CT scan was edited to obtain an anatomically correct distinction between air and mucosa. Next, a model was constructed with a stereolithographic technique using a UV-sensitive resin. To validate the model, a 3D CT scan of the model was made and compared to the anatomy of the original image. To study aerosol deposition, the model was connected to a breathing simulator. Medical aerosols were delivered to the model by MDI/spacer during stimulated breathing. An upper airway model was made of a 9-month-old child that needed reconstructive surgery for a skull deformity and with normal anatomy of the upper airways. The nasal airway of the model was open for air passage and the oral airway was closed. The CT scan of the model matched the original in vivo CT scan closely. Aerosol deposition measurements showed that dose passing the model, or lung dose, was comparable with in vivo lung deposition data. We have constructed an anatomically correct model of the upper airways of a child, using a stereolithographic method for in vitro studies of aerosol deposition in young children. This model will be used to obtain insight in aerosol treatment that cannot be obtained in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11791684     DOI: 10.1089/08942680152744640

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  25 in total

Review 1.  Ethical aspects of using radiolabelling in aerosol research.

Authors:  M L Everard
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

Review 2.  In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.

Authors:  Jolyon Mitchell; Steve Newman; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2007-12-21       Impact factor: 3.246

Review 3.  Essentials for aerosol delivery to term and pre-term infants.

Authors:  Andrew R Clark
Journal:  Ann Transl Med       Date:  2021-04

4.  Development of an infant complete-airway in vitro model for evaluating aerosol deposition.

Authors:  Karl Bass; P Worth Longest
Journal:  Med Eng Phys       Date:  2018-06-22       Impact factor: 2.242

5.  High-Efficiency Nose-to-Lung Aerosol Delivery in an Infant: Development of a Validated Computational Fluid Dynamics Method.

Authors:  Karl Bass; Susan Boc; Michael Hindle; Kelley Dodson; Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-12-15       Impact factor: 2.849

6.  Comparison of in vitro deposition of pharmaceutical aerosols in an idealized child throat with in vivo deposition in the upper respiratory tract of children.

Authors:  Conor A Ruzycki; Laleh Golshahi; Reinhard Vehring; Warren H Finlay
Journal:  Pharm Res       Date:  2014-01-07       Impact factor: 4.200

7.  Deposition of albuterol aerosol generated by pneumatic nebulizer in the Sophia Anatomical Infant Nose-Throat (SAINT) model.

Authors:  Beth L Laube; Gail Sharpless; Charles Shermer; Omer Nasir; Vincent Sullivan; Kenneth Powell
Journal:  Pharm Res       Date:  2010-05-22       Impact factor: 4.200

8.  Impact of airborne particle size, acoustic airflow and breathing pattern on delivery of nebulized antibiotic into the maxillary sinuses using a realistic human nasal replica.

Authors:  Lara Leclerc; Jérémie Pourchez; Gérald Aubert; Sandrine Leguellec; Laurent Vecellio; Michèle Cottier; Marc Durand
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

9.  Developing ways to evaluate in the laboratory how inhalation devices will be used by patients and care-givers: the need for clinically appropriate testing.

Authors:  Jolyon P Mitchell; Jason A Suggett
Journal:  AAPS PharmSciTech       Date:  2014-06-04       Impact factor: 3.246

Review 10.  Use of inhaler devices in pediatric asthma.

Authors:  Fernando Maria De Benedictis; David Selvaggio
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.